XML 26 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues $ 183 $ 1,608 $ 0
Cost of revenues 3,681 3,270 547
Gross loss (3,498) (1,662) (547)
Operating expenses:      
Research and development expenses, net 49,460 82,662 78,225
Selling, general and administrative expenses 26,171 35,568 49,200
Total operating expenses 75,631 118,230 127,425
Operating loss (79,129) (119,892) (127,972)
Income (loss) from warrants remeasurement (22,750) 396 17,929
Financial income (expenses), net (7,812) 3,928 4,371
Net loss before income tax (109,691) (115,568) (105,672)
Taxes on income (tax benefit) 2,063 (1,360) 1,748
Net loss (111,754) (114,208) (107,420)
Net comprehensive loss $ (111,754) $ (114,208) $ (107,420)
Weighted average number of ordinary shares used in computing basic net loss per share (in shares) [1] 15,933,291 10,087,691 9,783,301
Weighted average number of ordinary shares used in computing diluted net loss per share (in shares) [1] 15,933,291 10,087,691 9,783,301
Class A Ordinary Shares      
Operating expenses:      
Basic net loss per share (in USD per share) $ (7.01) $ (11.32) $ (10.98)
Diluted net loss per share (in USD per share) $ (7.01) $ (11.32) $ (10.98)
Weighted average number of ordinary shares used in computing basic net loss per share (in shares) 15,933,291 10,087,691 9,783,301
Weighted average number of ordinary shares used in computing diluted net loss per share (in shares) 15,933,291 10,087,691 9,783,301
[1] Prior period results have been retroactively adjusted to reflect the 1:30 stock reverse split effected on October 18, 2023. See also Note 10.